Venture Appalacia, Inc. and its Belief in Y(OU)
Past President and CEO of Diagnostic Hybrids
Dr. David Scholl received his Ph.D. from Ohio University in 1981 and was a post-doctoral fellow at the Roche Institute for Molecular Biology in Nutley, NJ through 1983. Dave served as President and CEO of Diagnostic Hybrids, Inc. (DHI) in Athens, Ohio from 1995 to 2010. One of DHI's early technology founders, Dave originally joined the company as Director of Research in 1983. Under his leadership and with an extraordinary management team, DHI grew from a four-person startup to the Inc. 500 list, emerging as a world leader in cell- and Monoclonal Antibody-based diagnostics. The company's dynamic growth led to an equity investment by Summit Partners (Palo Alto, CA) in 2004 and merger of the Company in February 2010 to Quidel Corporation of San Diego, California. Dave then joined the Quidel executive team as a Senior Vice President until his retirement in October 2011. DHI has seen significant growth in Athens since the merger as a subsidiary of Quidel. Dave currently serves professionally as a partner with Athenian Venture Partners, a venture capital firm that makes investments in private, high growth potential, technology based companies in the Information Technology and Biomedical Sciences space. Dr. Scholl has nearly 30 years of life sciences experience in research and development, executive management and venture capital. Dave volunteers his service to several boards and non-profit organizations including the Ohio Third Frontier Commission, BioOhio, Ohio University's Edison Biotechnology Institute and Manasseh Cutler Scholars Program, was president of the Foundation for Ichthyosis and Related Skin Types (FIRST), headquartered in Philadelphia, PA from 2006-2012, and he is currently a trustee of Ohio University and the Ohio University Foundation. In 2002, he was awarded the Leadership Award by the Ohio Association of People Supporting Employment First (APSE), an organization with an exclusive focus on integrated employment and career advancement for individuals with disabilities, in 2003 he was the recipient of the Central Ohio Ernst and Young Entrepreneur of the Year Award in Life Sciences, in 2004 he was awarded the Ohio University Alumni Medal of Merit for Achievement in the Sciences, in 2006 was awarded BioOhio's Bioscience Leadership Award, in 2010, Dave was awarded The Phillips Medal of Public Service by the Ohio University Heritage College of Osteopathic Medicine, and in 2012 was the recipient of the inaugural Konneker Medal for Innovation and Entrepreneurship.